BioSpace News Archive

Vir Biotechnology, Inc., a clinical-stage immunology company focused on treating and preventing serious infectious diseases, announced that George Scangos, Ph.D., Chief Executive Officer will virtually present at the BofA Securities 2020 Health Care Conference on Thursday, May 14th at 12:40 pm PT/ 3:40 pm ET.

Completed $15 million sale of manufacturing, office and laboratory facility to MD Anderson and entered into supply agreement

Homology Medicines, Inc., a genetic medicines company, announced financial results for the first quarter ended March 31, 2020, and highlighted recent accomplishments.

Ascendis Pharma A/S, a biopharmaceutical company that utilizes its innovative TransCon™ technologies to address unmet medical needs, announced that the company will hold a conference call and live webcast on Tuesday, May 19, 2020 at 4:30 p.m. Eastern Time to review its first quarter 2020 financial results and provide a business update.

Collaboration with Atreca and BeiGene to discover, develop and manufacture novel antibody treatment for COVID-19 announced

Positive long-term and interim data update from RGX-314 Phase I/IIa trial for wet AMD recently announced

Mirati Therapeutics, Inc., a clinical-stage targeted oncology company, reported financial results and a corporate update for the first quarter ended March 31, 2020.

Eiger BioPharmaceuticals, Inc., focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, reported financial results for first quarter 2020 and provided a business update.

Adamas Pharmaceuticals, Inc., a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, reported financial results for the first quarter ended March 31, 2020, as well as recent corporate highlights.

Apellis Pharmaceuticals, Inc. announced that the company approved the grant of equity awards to three new employees with grant dates of May 1, 2020 and May 4, 2020, as an equity inducement award outside of the company’s 2017 Stock Incentive Plan and material to the employee’s acceptance of employment with the company.